<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">The overall seroprevalence of HIV, HBV and HCV was 33.8% [27.8–40.5], 7.8% [4.9–12.1] and 50.2% [43.7–56.8], respectively. One hundred and fifty-one (68.9%) of PWID had serologic evidence of at least one infection, 49 (22.4%) had at least two infections, while one (0.5%) had serologic evidence of all the three viruses (Table 
 <xref rid="Tab2" ref-type="table">2</xref>). Considering co-infection, 0.9% had HIV + HBV, 16% had HIV + HCV and 6.4% had HBV + HCV. Among participants with HBV infection, 82.4% had also HCV (Table 
 <xref rid="Tab2" ref-type="table">2</xref>). There was no sex-stratified significant difference observed regarding the occurrence of HIV, HBV and HCV infections. 
</p>
